\
&
Contact us
\
&
Contact us
Published on | 4 years ago
Programmes Missions New European Bauhaus Horizon Europe JRC Green DealThe New European Bauhaus Initiative was officially launched by the European Commission on 18 January 2021. It aims to bring the European Green Deal closer to the people based on three core values: sustainability, accessibility and aesthetics. The initiative will be a creative and interdisciplinary space where architects, artists, students, scientists, engineers and designers can collaborate which each other in order to turn this vision into reality.
The New European Bauhaus will unfold in three phases: Design, Delivery and Dissemination.
The European Commission will organise a series of online info sessions where the European Bauhaus Team will present this new initiative and the opportunities to contribute to this Bauhaus initiative. The full schedule of the online info sessions can be found here or on our events page. The first one is planned for 15 February and can be followed by livestream.
To learn more on this initiative, you can also visit the New European Bauhaus website or have a quick look at this Two Page Note - ‘New European Bauhaus explained'.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Research Infrastructures Horizon Europe Digital Europe
Building on the revised Charter for access to research infrastructures , this new Charter will be specifically aimed at facilitating access of companies. It will make it easier for companies, especially small and medium-sized businesses (SMEs), startups and scaleups, to access Europe’s world-class research and technology... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
